02 August 2013

Bruton & Fitzgerald Announce $100 million Investment at Pfizer Plant in Grange Castle

Multinational pharmaceutical giant Pfizer this week announced a $100 million investment in their Grange Castle site in Dublin. The announcement was made by Minister Richard Bruton and local Minister Frances Fitzgerald who attended a press conference at the Pfizer plant in Clondalkin this week.

Speaking at the announcement Minister Fitzgerald stated; “I am delighted to join Dr. Duffy and my colleague Minister Bruton to mark today’s announcement of Pfizer’s €130 million investment in two Irish manufacturing sites. This positive news is a vote of confidence in our economy and our workforce. Two years ago, shortly after becoming Minister, I visited this site and I was delighted to meet the Site Leader Mr. Julien Deneve and to get a tour of the facility and to meet so many members of their workforce from the wider Clondalkin and Lucan areas.

“As an Irish Government Minister, I wish to acknowledge Pfizer’s commitment to investing in Ireland, to creating jobs and to supporting our economy. As a local TD, I wish to acknowledge Pfizer’s important role as a major local employer and driver of our local economy here in West Dublin. But most importantly I wish to acknowledge Pfizer’s ongoing commitment to research, development and innovation. Their work in discovering and manufacturing cutting edge new medicines is meeting previously unmet and emerging medical needs; and ultimately improving the quality of life for so many; and in a lot of cases saving lives,” continued Fitzgerald.



The Minister went on to pay tribute to the South Dublin County Council describing them as innovative “on their initiative and investment in Grange Castle Business Park; and in attracting and sustaining world-class facilities such as the Pfizer facility we have on our doorstep.”

“I look forward to Pfizer continuing to invest and innovate; and to flourish and grow and hope that the local economy and jobs market in our area can continue to benefit from Pfizer and other inward investments,” concluded Fitzgerald.